Short Interest in CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Decreases By 36.3%

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the target of a large decrease in short interest in the month of May. As of May 29th, there was short interest totaling 582 shares, a decrease of 36.3% from the May 14th total of 913 shares. Based on an average daily volume of 3,299 shares, the days-to-cover ratio is presently 0.2 days.

CSPC Pharmaceutical Group Trading Down 1.8%

Shares of CSPC Pharmaceutical Group stock traded down C$0.07 on Tuesday, hitting C$3.63. 357 shares of the company traded hands, compared to its average volume of 3,762. CSPC Pharmaceutical Group has a 52 week low of C$3.45 and a 52 week high of C$5.83. The business has a 50-day simple moving average of C$4.15 and a 200 day simple moving average of C$4.45.

CSPC Pharmaceutical Group Company Profile

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.